Jacqueline Scanlan - 07 Jun 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Jun 2021, 16:33:12 UTC
Prior SEC filing
21 May 2021
Next SEC filing
16 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Scanlan

Key filing fact

Jacqueline Scanlan filed Form 4 for HAEMONETICS CORP (HAE) on 09 Jun 2021.

Key facts

  • This page summarizes Jacqueline Scanlan's Form 4 filing for HAEMONETICS CORP (HAE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Jun 2021, 16:33.

Change

  • Previous filing in this sequence was filed on 21 May 2021.
  • Current net transaction value: -$10,743.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Sale

Transaction value
$10,743
Shares
-195
Change %
-4.4%
Price
$55.09
Shares after
4,216
Date
07 Jun 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Footnote F2

This number includes unvested RSUs previously reported.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .